Rogel Cancer Center names two new leaders to enhance patient care at U-M and statewide
The U-M Health Rogel Cancer Center has named David C. Smith, M.D., chief medical officer and associate director for cancer clinical services, and Shruti Jolly, M.D., associate director for the Michigan Medicine statewide cancer network.
The two positions will serve to further align Rogel’s efforts and initiatives with those across Michigan Medicine and at affiliates and partners throughout the state.
Smith, professor of hematology/oncology, is also the associate chief clinical officer for cancer at Michigan Medicine. Jolly, professor of radiation oncology, is the associate chief clinical strategy officer for cancer services at Michigan Medicine.
“We are thrilled to solidify these two important roles as part of our mission to be a leader in cancer prevention, early diagnosis, optimal treatment and care for all at risk of or affected by cancer. Dr. Smith’s and Dr. Jolly’s appointments will allow us to enhance access to the highest quality cancer care and improve cancer outcomes and quality of life for all cancer patients and survivors across the state,” said Eric Fearon, M.D., Ph.D., director of the Rogel Cancer Center.
As chief medical officer and associate director for cancer clinical services, Smith will be charged with promoting and enhancing cancer clinical operations and clinical research opportunities at Rogel cancer care clinics and affiliated sites. He will focus on creating the optimal patient experience, increasing access to clinical research and enhancing workforce diversification and satisfaction. Smith joined the U-M faculty in 1996. He specializes in the care of patients with urologic cancers.
Jolly’s role will be to promote and advance a statewide system of cancer care and research. She also serves as the executive director of the Cancer Network of West Michigan, a partnership among Michigan Medicine, University of Michigan Health-West, the Lacks Cancer Center at St. Mary’s and the Johnson Family Cancer Center at Mercy Muskegon. This and other statewide affiliations and partnerships are designed to ensure all Michigan residents can receive high-quality cancer care close to home. Jolly joined the U-M faculty in 2007 and treats patients with thoracic, gynecologic and endocrine cancers.
As part of the Rogel executive committee, Smith and Jolly will work with leaders in the areas of research, diversity and inclusion, community outreach and education to coordinate efforts across all the center’s initiatives.
The appointments were effective Jan. 1.